Sineoculis homeobox homolog 1 protein overexpression as an independent biomarker for pancreatic ductal adenocarcinoma

Experimental and Molecular Pathology

Volumn 96, Issue 1, 2014, Pages 54-60

  Jin, Aihua ^a   Xu, Yunjie ^b   Liu, Shusen ^b   Jin, Tiefeng ^a,b   Li, Zhuhu ^a,b   Jin, Haiyan ^a   Lin, Lijuan ^b,c   Lin, Zhenhua ^a,b  

^a YANBIAN UNIVERSITY   (China)

^b YANBIAN UNIVERSITY MEDICAL COLLEGE   (China)

^c EASTERN LIAONING UNIVERSITY   (China)

Author keywords

Biomarker; Pancreatic ductal adenocarcinoma; Sineoculis homeobox homolog 1; Survival rate

Indexed keywords

TRANSCRIPTION FACTOR SIX1;

ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CANCER GRADING; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; CYTOPLASM; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OVERALL SURVIVAL; PANCREAS ADENOCARCINOMA; PANCREAS SURGERY; PREDICTION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SURVIVAL RATE; TUMOR VOLUME; UPREGULATION;

BIOMARKER; PANCREATIC DUCTAL ADENOCARCINOMA; SINEOCULIS HOMEOBOX HOMOLOG 1; SURVIVAL RATE;

ADENOCARCINOMA; ADULT; AGED; CARCINOMA, PANCREATIC DUCTAL; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HOMEODOMAIN PROTEINS; HUMANS; IMMUNOENZYME TECHNIQUES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; PANCREAS; PANCREATIC NEOPLASMS; PROGNOSIS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 84889564346     PISSN: 00144800     EISSN: 10960945     Source Type: Journal    
DOI: 10.1016/j.yexmp.2013.11.003     Document Type: Article

References (34)

1. Behbakht K., et al. Six1 overexpression in ovarian carcinoma causes resistance to TRAIL-mediated apoptosis and is associated with poor survival. Cancer Res. 2007, 67:3036-3042.
2. Chatterjee D., et al. Perineural and intraneural invasion in posttherapy pancreaticoduodenectomy specimens predicts poor prognosis in patients with pancreatic ductal adenocarcinoma. Am. J. Surg. Pathol. 2012, 36:409-417.
3. Coletta R.D., et al. The six1 homeoprotein stimulates tumorigenesis by reactivation of cyclin A1. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:6478-6483.
4. Coletta R.D., et al. Six1 overexpression in mammary cells induces genomic instability and is sufficient for malignant transformation. Cancer Res. 2008, 68:2204-2213.
5. Elzagheid A., et al. Prognostication of invasive ductal breast cancer by quantification of E-cadherin immunostaining: the methodology and clinical relevance. Histopathology 2002, 41:127-133.
6. Farabaugh S., et al. Eya2 is required to mediate the pro-metastatic functions of Six1 via the induction of TGF-β signaling, epithelial-mesenchymal transition, and cancer stem cell properties. Oncogene 2012, 31:552-562.
7. Fougerousse F., et al. Six and Eya expression during human somitogenesis and MyoD gene family activation. J. Muscle Res. Cell Motil. 2002, 23:255-264.
8. Guo C., et al. A Tbx1-Six1/Eya1-Fgf8 genetic pathway controls mammalian cardiovascular and craniofacial morphogenesis. J. Clin. Invest. 2011, 121:1585-1595.
9. Hendry C.E., et al. Direct transcriptional reprogramming of adult cells to embryonic nephron progenitors. J. Am. Soc. Nephrol. 2013, 24:1424-1434.
10. Ikeda K., et al. Six1 is indispensable for production of functional progenitor cells during olfactory epithelial development. Int. J. Dev. Biol. 2010, 54:1453-1464.
11. Iwanaga R., et al. Expression of Six1 in luminal breast cancers predicts poor prognosis and promotes increases in tumor initiating cells by activation of extracellular signal-regulated kinase and transforming growth factor-beta signaling pathways. Breast Cancer Res. 2012, 14:R100.
12. Jemal A., et al. Cancer statistics, 2010. CA Cancer J. Clin. 2010, 60:277-300.
13. Jin J., et al. Ezrin overexpression predicts the poor prognosis of gastric adenocarcinoma. Diagn. Pathol. 2012, 7:135.
14. Laclef C., et al. Thymus, kidney and craniofacial abnormalities in Six 1 deficient mice. Mech. Dev. 2003, 120:669-679.
15. Lee S.H., et al. Breast cancer resistance protein expression is associated with early recurrence and decreased survival in resectable pancreatic cancer patients. Pathol. Int. 2012, 62:167-175.
16. Li P., et al. Heterogeneous expression and functions of androgen receptor co-factors in primary prostate cancer. Am. J. Pathol. 2002, 161:1467-1474.
17. Li X., et al. Eya protein phosphatase activity regulates Six1-Dach-Eya transcriptional effects in mammalian organogenesis. Nature 2003, 426:247-254.
18. Li D., et al. Pancreatic cancer. Lancet 2004, 363:1049-1057.
19. Li Z., et al. Six1 promotes proliferation of pancreatic cancer cells via upregulation of cyclin D1 expression. PLoS One 2013, 8:e59203.
20. McCoy E.L., et al. Six1 expands the mouse mammary epithelial stem/progenitor cell pool and induces mammary tumors that undergo epithelial-mesenchymal transition. J. Clin. Invest. 2009, 119:2663-2677.
21. Ng K.T., et al. Clinicopathological significance of homeoprotein Six1 in hepatocellular carcinoma. Br. J. Cancer 2006, 95:1050-1055.
22. Ng K.T., et al. Suppression of tumorigenesis and metastasis of hepatocellular carcinoma by shRNA interference targeting on homeoprotein Six1. Int. J. Cancer 2010, 127:859-872.
23. Oliver G., et al. Homeobox genes and connective tissue patterning. Development 1995, 121:693-705.
24. Ozaki H., et al. Six1 controls patterning of the mouse otic vesicle. Development 2004, 131:551-562.
25. Qamar L., et al. Specificity and prognostic validation of a polyclonal antibody to detect Six1 homeoprotein in ovarian cancer. Gynecol. Oncol. 2012, 125:451-457.
26. Relaix F., Buckingham M. From insect eye to vertebrate muscle: redeployment of a regulatory network. Genes Dev. 1999, 13:3171-3178.
27. Tan J., et al. Expression and significance of Six1 and Ezrin in cervical cancer tissue. Tumour Biol. 2011, 32:1241-1247.
28. Wan F., et al. Gene expression changes during HPV-mediated carcinogenesis: a comparison between an in vitro cell model and cervical cancer. Int. J. Cancer 2008, 123:32-40.
29. Wang C.A., et al. SIX1 induces lymphangiogenesis and metastasis via upregulation of VEGF-C in mouse models of breast cancer. J. Clin. Invest. 2012, 122:1895-1906.
30. Wu W., et al. Subcellular localization of different regions of porcine Six1 gene and its expression analysis in C2C12 myoblasts. Mol. Biol. Rep. 2012, 39:9995-10002.
31. Xu P.X., et al. Six1 is required for the early organogenesis of mammalian kidney. Development 2003, 130:3085-3094.
32. Yu Y., et al. Expression profiling identifies the cytoskeletal organizer ezrin and the developmental homeoprotein Six-1 as key metastatic regulators. Nat. Med. 2004, 10:175-181.
33. Yu Y., et al. The homeoprotein six1 transcriptionally activates multiple protumorigenic genes but requires ezrin to promote metastasis. Cancer Res. 2006, 66:1982-1989.
34. Zheng W., et al. The role of Six1 in mammalian auditory system development. Development 2003, 130:3989-4000.